Skip to main content

SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

SkinBioTherapeutics shortlisted for Biotech and Money 2017 Awards

SkinBioTherapeutics plc a life science company focused on skin health, has been nominated as a finalist in the Life Science IPO of the Year category of the Biotech and Money 2017 Awards.

The 2017 Biotech and Money Assembly and Awards Gala Dinner celebrates the UK’s funding, finance and investment success in the life sciences sector over the past 12 months.

SkinBioTherapeutics has been nominated for its IPO in April 2017 which raised £4.5 million in funds to enable the development of its proprietary SkinBiotix® technology platform and to accelerate the clinical development of its main therapeutic candidates. Their aim is to target cosmetic products, infection control and dermatological conditions.